| Gene symbol | STAT3 | Synonyms | ADMIO, ADMIO1, APRF, HIES | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17q21.2 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | signal transducer and activator of transcription 3 | ||||
| GTO ID | GTC0245 |
| Trial ID | NCT02417753 |
| Disease | Gastrointestinal Allergy | Ovarian Cancer |
| Altered gene | STAT3 |
| Therapeutic/Target gene | Target gene |
| Therapy | ASO |
| Treatment | ISIS 481464|Danvatirsen|ISIS-STAT3rx|AZD9150|IONIS-STAT3-2.5Rx |
| Phase | Phase2 |
| Recruitment status | Terminated |
| Title | A Pilot Study of AZD9150, a STAT3 Antisense Oligonucleotide in Malignant Ascites |
| Year | 2015 |
| Country | United States |
| Company sponsor | National Cancer Institute (NCI) |
| Other ID(s) | 150112|15-C-0112 |
| Vector information | |||
|
|||
| Cohort1: dose level 1 | |||||||||||
|
|||||||||||
| Cohort2: dose level 2 | |||||||||||
|
|||||||||||